MedTrace Logo

Living With Frontotemporal Dementia

NCT01738386 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 16

Last updated 2018-07-26

No results posted yet for this study

Summary

Background:

\- Frontotemporal dementia (FTD) is the second most common cause of early-onset dementia. Alzheimer s disease is the most common. Alzheimer s disease happens most often in the elderly, but FTD typically appears between 40 and 60 years of age. It also has a strong genetic component: Up to 40% of FTD cases are linked to positive family histories. Earlier diagnoses and genetic tests mean that people with FTD will spend more years in earlier stages of disease, aware that they have it. However, few studies have looked at the personal experiences or coping styles of people with FTD. Researchers want to interview people with FTD and their caregivers to understand their experiences with the disease. This information will help create better treatments and therapies for those affected by FTD.

Objectives:

\- To study the experiences of persons with FTD and their primary caregivers.

Eligibility:

* Individuals at least 18 years of age who have been diagnosed with FTD.
* Primary caregivers (spouse or partner at least 18 years of age) of individuals who have been diagnosed with FTD.

Design:

* Before FTD participants are recruited, a pilot study will test the interview questions. This pilot study will be given to people with Alzheimer s disease and their caregivers. It will study how well people with dementia understand the interview questions.
* FTD study participants will be recruited through dementia care centers.
* All participants will have in-person interviews. These interviews will take up to 1 hour.
* Participants with FTD will answer questions about their experience with the disease. They will talk about their mental abilities, challenges, and coping strategies.
* Caregivers will answer questions about their experience in caring for someone with FTD. They will talk about their challenges and coping strategies. They will also talk about the person with FTD, and how aware they believe that the person is of the dementia symptoms.
* All participants will receive a small gift card as compensation for their time.
* No treatment will be provided as part of this study.

Conditions

  • Adaptation

Sponsors & Collaborators

  • National Human Genome Research Institute (NHGRI)

    lead NIH

Principal Investigators

  • Barbara B Biesecker · National Human Genome Research Institute (NHGRI)

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-06-13
Completion
2016-02-24

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01738386 on ClinicalTrials.gov